A quantitative index measured on 99mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease

Japanese Journal of Radiology

Volumn 30, Issue 5, 2012, Pages 435-441

  Yoshida, Morikatsu ^a   Shiraishi, Shinya ^a   Sakaguchi, Fumi ^a   Utsunomiya, Daisuke ^a   Tashiro, Kuniyuki ^b   Tomiguchi, Seiji ^c   Okabe, Hirohisa ^a   Beppu, Toru ^a   Baba, Hideo ^a   Yamashita, Yasuyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO CITY HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

99mTc GSA SPECT CT 3D fused image; Chronic liver disease; Functional liver index; Liver cirrhosis; Liver uptake ratio

Indexed keywords

GALACTOSYLNEOGLYCOALBUMIN TC 99M;

AGED; ARTICLE; BIOCHEMISTRY; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIOACTIVITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

AGED; FEMALE; HEPATITIS, CHRONIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865978978     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-012-0072-9     Document Type: Article

References (33)

1. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229: 210-5.
2. Eckelman WC, Reba RC, Gibson RE, Rzeszotarski WJ, Vieras F, Mazaitis JK, et al. Receptor-binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med. 1979;20:350-7.
3. Ha-Kawa SK, Kojima M, Suga Y, Kurokawa H, Itagaki Y, Tanaka Y. Dose estimation of Tc-99m-DTPA-galactosyl-human serum albumin (Tc-99m-GSA) in the blood with nonlinear regression method. Kaku Igaku. 1991;28:425-8.
4. Shuke N, Okizaki A, Kino S, Sato J, Ishikawa Y, Zhao C, et al. Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT. J Nucl Med. 2003;44:475-82.
5. Kaibori M, Ha-Kawa SK, Ishizaki M, Matsui K, Saito T, Kwon AH, et al. HA/GSA-Rmax ratio as a predictor of postoperative liver failure. World J Surg. 2008;32:2410-8.
6. Miki K, Kubota K, Kokudo N, Inoue Y, Bandai Y, Makuuchi M. Asialoglycoprotein receptor and hepatic blood flow using technetium- 99m-DTPA-galactosyl human serum albumin. J Nucl Med. 1997;38:1798-807.
7. Iimuro Y, Kashiwagi T, Yamanaka J, Hirano T, Saito S, Sugimoto T, et al. Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver fromCT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci. 2010;17:673-81.
8. Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed (99m)Tc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol. 2011;46(7):938-43.
9. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:8.
10. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377-82.
11. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Preoperative regional maximal removal rate of technetium-99m- galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 1995;117:429-34.
12. Kokudo N, Vera DR, Makuuchi M. Clinical application of TcGSA. Nucl Med Biol. 2003;30:845-9.
13. Tanaka A, Shinohara H, Hatano E, Sato S, Kanazawa A, Yamaoka Y, et al. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium99m galactosyl human serum albumin. Hepatogastroenterology. 1999;46:369-75.
14. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev. 1971;51:23-65 (Review).
15. Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol. 1974;41:99-128.
16. Marshall JS, Green AM, Pensky J, Williams S, Zinn A, Carlson DM. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Investig. 1974;54:555-62.
17. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology. 1981;81: 527-33.
18. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, KamiyamaY. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426-9.
19. Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabe J, et al. Clinical usefulness of scintigraphy with 99mTc-galactosylhuman serum albumin for prognosis of cirrhosis of the liver. J Nucl Med. 1999;40:1652-6.
20. Kira T, Tomiguchi S, Takahashi M, Yoshimatsu S, Sagara K, Kurano R. Correlation of 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med. 1999;17:125-30.
21. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium- 99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med. 1991;32: 2233-40.
22. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium- 99m-galactosyl-neoglycoalbumin. J Nucl Med. 1991;32:1169-76.
23. Sugahara K, Togashi H, Takahashi K, Onodera Y, Sanjo M, Misawa K, et al. Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology. 2003;38:1401-9.
24. Zeintl J, Vija AH, Yahil A, Hornegger J, Kuwert T. Quantitative accuracy of clinical 99mTc SPECT/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction. J Nucl Med Off Publ Soc Nucl Med. 2010;51:921-8.
25. Seo Y, Wong KH, Sun M, Franc BL, Hawkins RA, Hasegawa BH. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. J Nucl Med. 2005;46:868-77.
26. Kashiwagi T, Yutani K, Fukuchi M, Naruse H, Iwasaki T, Yokozuka K, et al. Correction of nonuniform attenuation and image fusion in SPECT imaging by means of separate X-ray CT. Ann Nucl Med. 2002;16:255-61.
27. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 1998;5:187-92.
28. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Investig. 1966;45:645-57.
29. Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 1985;5:638-42.
30. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Postprandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med. 1998;37:568-75.
31. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-26.
32. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001;96:3142-6.
33. Matsuzaki S, Onda M, Tajiri T, Kim DY. Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve. Hepatology. 1997;25:828-32.